SCHEMBL4428683

SCHEMBL4428683

COCc1oc(-c2nn(Cc3ccccc3)c3ccccc23)nc1C

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 8/20 0.61
CYP2D6 P10635 8/20 0.52
CYP1A2 P05177 6/20 0.52
CYP3A4 P08684 2/20 0.52
SCN8A Q9UQD0 1/20 0.52
KDM4E B2RXH2 2/20 0.47
NPC1 O15118 1/20 0.47
GMNN O75496 1/20 0.47
ALDH1A1 P00352 1/20 0.47
LMNA P02545 1/20 0.47
TP53 P04637 1/20 0.47
MAPT P10636 1/20 0.47
CYP2C9 P11712 1/20 0.47
HPGD P15428 1/20 0.47
ALOX15 P16050 1/20 0.47
NFKB1 P19838 1/20 0.47
MAPK1 P28482 1/20 0.47
CYP2C19 P33261 1/20 0.47
RAB9A P51151 1/20 0.47
BLM P54132 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13865173 0.89 PDE5A (0.53) PDE5ACYP2D6CYP1A2CYP3A4SCN8A
SCHEMBL4424864 0.86 F2RL3 (0.52) PDE5ACYP2D6CYP1A2CYP3A4SCN8A
SCHEMBL4429083 0.86 PDE5A (0.58) PDE5ACYP2D6CYP1A2CYP3A4SCN8A
SCHEMBL4434101 0.85 BUB1 (0.45) PDE5ACHRM1
SCHEMBL13865176 0.83 PDE5A (0.62) PDE5ACYP2D6CYP1A2CYP3A4SCN8A
SCHEMBL7659743 0.81 CYP1A2 (0.51) PDE5ACYP2D6CYP1A2SCN8AKDM4E
SCHEMBL27524575 0.80 PDE5A (0.51) PDE5ACYP2D6CYP1A2CYP3A4SCN8A
SCHEMBL4849350 0.76 PDE5A (1.00) PDE5ACYP2D6CYP1A2CYP3A4SCN8A
SCHEMBL13865213 0.74 CYP2D6 (0.72) PDE5ACYP2D6CYP1A2CYP3A4SCN8A
SCHEMBL6450408 0.73 PDE5A (0.60) PDE5ACYP2D6CYP1A2CYP3A4SCN8A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0934311-B1 NEW HETEROCYCLYLMETHYL-SUBSTITUTED PYRAZOL DERIVATES BAYER HEALTHCARE AG (DE) 2009-05-13 EP disclosed
EP-0934311-B1 NEW HETEROCYCLYLMETHYL-SUBSTITUTED PYRAZOL DERIVATES BAYER HEALTHCARE AG (DE) 2009-05-13 EP disclosed
EP-1686127-A1 New heterocyclylmethyl-substituted pyrazole derivatives and their use for treating cardiovascular diseases Bayer HealthCare AG (DE) 2006-08-02 EP disclosed
US-6462068-B1 CARDIOVASCULAR DISEASES BAYER AKTIENGESELLSCHAFT (DE) 2002-10-08 US disclosed
US-6414009-B1 CARDIOVASCULAR DISORDERS; ANTICOAGULANTS BAYER AKTIENGESELLSCHAFT (DE) 2002-07-02 US disclosed
US-6410740-B1 CYCLIZATION OF THE CORRESPONDING AMIDE BAYER AKTIENGESELLSCHAFT (DE) 2002-06-25 US disclosed
US-6387940-B1 CARDIOVASCULAR DISORDERS BAYER AKTIENGESELLSCHAFT (DE) 2002-05-14 US disclosed
US-6166027-A Heterocyclylmethyl-substituted pyrazole derivatives and their use for treating cardiovascular diseases BAYER AKTIENGESELLSCHAFT (DE) 2000-12-26 US disclosed
CN-1241188-A Heterocyclylmethyl-substed pyrazol derivs. BAYER AG (DE) 2000-01-12 CN disclosed
EP-0934311-A2 NEW HETEROCYCLYLMETHYL-SUBSTITUTED PYRAZOL DERIVATES BAYER AG (DE) 1999-08-11 EP disclosed
WO-1998016507-A2 NEW HETEROCYCLYLMETHYL-SUBSTITUTED PYRAZOL DERIVATES AND THEIR USE FOR TREATING CARDIOVASCULAR DISEASES BAYER AKTIENGESELLSCHAFT (DE) 1998-04-23 WO disclosed